论文部分内容阅读
目的:探讨米索前列醇配伍缩宫素预防中期妊娠引产后出血的临床效果。方法:将我院中期妊娠引产患者60例随机分为观察组和对照组,对照组给予单纯缩宫素防治,观察组同时给予米索前列醇防治,评估2组临床治疗效果。结果:观察组患者产后2小时及24小时出血量明显少于对照组(P<0.05)。观察组患者第3产程时间、产后出血发生率明显少于对照组(P<0.05)。观察组患者宫底恢复情况以及宫缩强度明显优于对照组(P<0.05)。结论:米索前列醇配伍缩宫素预防中期妊娠引产后出血的临床效果明显,值得应用。
Objective: To investigate the clinical effect of misoprostol combined with oxytocin in preventing postpartum hemorrhage in mid-term pregnancy. Methods: 60 cases of induced abortion in our hospital were randomly divided into observation group and control group. The control group was treated with oxytocin alone. The observation group was treated with misoprostol to evaluate the clinical effects of the two groups. Results: The bleeding volume in observation group was significantly less than that in control group at 2 hours and 24 hours postpartum (P <0.05). Observation group patients in the third stage of labor, the incidence of postpartum hemorrhage was significantly less than the control group (P <0.05). The recovery of uterine fundus and the intensity of contractions in the observation group were significantly better than those in the control group (P <0.05). Conclusion: Misoprostol combined with oxytocin to prevent bleeding after induction of labor in the second trimester of pregnancy clinical effect is obvious, it is worth applying.